Drug Patents owned by Horizon Therap

1. List of Ravicti drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10183005 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs
Sep, 2030

(7 years from now)

US10183006 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs
Sep, 2030

(7 years from now)

US10045958 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs
Sep, 2030

(7 years from now)

US10183003 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs
Sep, 2030

(7 years from now)

US10183002 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs
Sep, 2030

(7 years from now)

US10183004 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs
Sep, 2030

(7 years from now)

US9962359 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs
Sep, 2030

(7 years from now)

US8642012 HORIZON THERAP Methods of treatment using ammonia-scavenging drugs
Sep, 2030

(7 years from now)

US10045959 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs
Sep, 2030

(7 years from now)

US9999608 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs
Sep, 2030

(7 years from now)

US9561197 HORIZON THERAP Methods of therapeutic monitoring of phenylacetic acid prodrugs
Sep, 2030

(7 years from now)

US10668040 HORIZON THERAP Treatment of urea cycle disorders in neonates and infants
Sep, 2030

(7 years from now)

US9254278 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs
Mar, 2032

(9 years from now)

US8404215 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging
Mar, 2032

(9 years from now)

US9326966 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs
Mar, 2032

(9 years from now)

US9095559 HORIZON THERAP Methods of therapeutic monitoring of nitrogen scavenging drugs
Mar, 2032

(9 years from now)

Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Apr 28, 2024

Drugs and Companies using GLYCEROL PHENYLBUTYRATE ingredient

Market Authorisation Date: 01 February, 2013

Treatment: Treatment of a urea cycle disorder; Dosage adjustment of a nitrogen scavenging drug in the treatment of a urea cycle disorder

Dosage: LIQUID;ORAL

How can I launch a generic of RAVICTI before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in